Appeals Court Affirms Dismissal of Lipitor Diabetes Litigation
A federal appeals court has affirmed a decision to dismiss thousands of Lipitor diabetes claims after a federal judge excluded crucial expert witness testimony on causation.
A federal appeals court has affirmed a decision to dismiss thousands of Lipitor diabetes claims after a federal judge excluded crucial expert witness testimony on causation.
A new study warns that the use of Lipitor, Zocor and similar cholesterol drugs may increase the risk of Parkinson's disease, particularly during the first year of use.
Thousands of plaintiffs have been ordered to produce new expert testimony linking Lipitor to an increased risk of diabetes or have their cases dismissed following summary judgment and exclusion of…
A health task force is calling for increased use of cholesterol drugs known as statins to prevent heart disease in older Americans, despite concerns over side effects such as increased…
A federal judge is restricting plaintiffs' expert testimony in Lipitor lawsuits to causation involving only the highest doses of the cholesterol drug, which thousands of women say caused them to…
A new study found that Lipitor failed to decrease the risks of acute kidney injury after heart surgery.
Three Lipitor lawsuits involving plaintiffs who took 80mg doses of the cholesterol drug and claim they developed diabetes are being worked up for trial in July.
The first bellwether trial in Lipitor diabetes litigation has been delayed as the court waits for additional briefings on witnesses who intend to testify showing how the cholesterol drug can…
Danish researchers have found that people who become aware of potential cholesterol drug side effects through the media are at an increased likelihood of stopping use of the drugs prematurely.
Attorneys in Lipitor diabetes litigation have been asked by a federal judge to provide additional briefing on claims that Pfizer improperly marketed Lipitor as effective in women, and whether those…